AstraZeneca (AZN) said it is investing $50 billion in US manufacturing by 2030, following the lead of big pharma peers that ...

President Trump's made in American manufacturing push will benefit some sectors over others, Oxford Economics said.

AstraZeneca AZN has unveiled a sweeping $50 billion investment plan in the United States, to be executed by 2030. The ...

U.S. factory production edged up in June as a decline in motor vehicle output was offset by gains elsewhere, though ...